Akèy › Timè nan sèvo › Maryland
Etid klinik pou Timè nan sèvo nan Maryland
18 etid pou Timè nan sèvo ap chèche patisipan nan sit nan Maryland.
Vil nan Maryland
Tèks ofisyèl etid la (Anglè)
Tumor Related Epilepsy
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyon
Laj 8 a 99 · Tout sèks · Mizajou Oct 2, 2026 · NCT02639325Evaluation and Treatment of Neurosurgical Disorders
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyon
Laj 4 a 99 · Tout sèks · Mizajou Sep 29, 2026 · NCT00060541Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- Johns Hopkins Sidney Kimmel Cancer Center - Baltimore, Baltimore
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07326566Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 1/2
Laj 18 a 99 · Tout sèks · Mizajou Sep 28, 2026 · NCT07416188A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
- Johns Hopkins Hospital, Baltimore
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07492680A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 1/2
Laj 15 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT05588141A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
- The Johns Hopkins Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine, Baltimore
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 21, 2026 · NCT06764940Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets
- University of Maryland, Baltimore
Ap rekriteFaz 3
Laj 18 a 100 · Tout sèks · Mizajou Aug 19, 2026 · NCT05317858Pre-Operative or Post-Operative Stereotactic Radiosurgery in Treating Patients With Operative Metastatic Brain Tumors
- NIH Clinical Center, Bethesda
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT03750227PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 1/2
Laj 18 a 120 · Tout sèks · Mizajou Aug 12, 2026 · NCT06161519Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma
- Johns Hopkins Hospital, Baltimore
Ap rekrite
Jiska laj 39 · Tout sèks · Mizajou Jul 13, 2026 · NCT06796543Cognitive Outcomes After Brain Substructure-informed Radiation Planning in Pediatric Patients
- Johns Hopkins Hospital, Baltimore
Ap rekriteVolontè an sante akeyi
Laj 1 a 26 · Tout sèks · Mizajou Jun 29, 2026 · NCT05658731REMASTer: REcurrent Brain Metastases After SRS Trial
- University of Maryland, Baltimore
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 18, 2026 · NCT05124912Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
- Walter Reed National Military Medical Center, Bethesda
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Jun 9, 2026 · NCT03550391LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)
- Maryland Proton Treatment Center, Baltimore
- University of Maryland Greenebaum Cancer Center, Baltimore
- UCH Kaufman Cancer Center, Bel Air
- ak 2 plis
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2026 · NCT04699773Precision Radiotherapy Enabled by Molecular MRI
- Johns Hopkins University, Baltimore
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2026 · NCT07512154Pediatric Radiation Therapy Registry
- Johns Hopkins Hospital, Baltimore
Ap rekriteEtid obsèvasyon
Laj 0 a 26 · Tout sèks · Mizajou Nov 5, 2025 · NCT07129317S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- UM Upper Chesapeake Medical Center, Bel Air
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 8, 2025 · NCT03418961Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.